Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
1,,,-(3,3',3'',3'''-((2S,5S,8S,11S,14S,17S,20S)-14,17,20-tris(naphthalen-2-ylmethyl)-3,6,9,12,15,18,21-heptaoxo-1,4,7,10,13,16,19-heptaazacyclohenicosane-2,5,8,11-tetrayl)tetrakis(propane-3,1-diyl))tetraguanidine
ID: ALA5209232
Chembl Id: CHEMBL5209232
PubChem CID: 168294739
Max Phase: Preclinical
Molecular Formula: C63H81N19O7
Molecular Weight: 1216.47
Associated Items: